In recent years, crystal meth (methamphetamine) and ecstasy (MDMA) have become some of America’s top problem drugs. Meth can cause severe problems in the cardiovascular and central nervous systems. Furthermore, because there is no way to remove the drug from the body, therapies tend to focus on treating its side-effects.

But antibodies that bind to methamphetamines and methamphetamine-like compounds to effectively remove them from the bloodstream could change that. Michael Owens, director of the Center for Alcohol and Drug Abuse at the University of Arkansas, US, and colleagues claim to have developed a way to generate them.

Read the rest at the New Scientist

« »